Kathy Gibson

Kathy Gibson has extensive work experience in various roles within the scientific community. Kathy currently serves as the Chief Innovation and Strategic Alliances Officer at CAS, a division of the American Chemical Society. In this position, they are responsible for developing and leading partnerships and collaborations with customers, start-ups, and academic and established players. Kathy also leads a diverse team in assessing, developing, and implementing initiatives and activities to build innovative products and services for CAS customers worldwide.

Prior to their current role, Kathy founded Helio Consulting, Inc in 2008 and served as the President. Kathy also worked at ResultWorks - An Astrix Business as a Principal Consultant responsible for leading their digital transformation and data governance practice for healthcare and life sciences organizations.

Kathy also has experience at CAS, where they previously held the role of Chief Innovation Officer from 2015 to 2020. Before that, they worked at Pfizer in various roles, including Vice President Innovation, Vice President, World Wide Research Informatics, Sr. Director, Advanced Research Technologies, and Director, Research Informatics.

Overall, Kathy has a strong background in innovation, strategic alliances, and leadership within the scientific and healthcare industries.

Kathy Gibson's education history includes attending Harvard Business School from 2000 onwards, where they pursued a degree in Executive Leadership through the Program for Leadership Development. Prior to that, they had also studied at the University of Houston, although specific details regarding the degree or field of study are not provided. In addition to their formal education, Kathy Gibson obtained a certification in Strategic Partnerships from LinkedIn in February 2021.